Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Parmax Pharma Ltd - 540359 - Annual General Meeting Of The Company Is Scheduled To Be Held On Friday 27Th September, 2019.

 This is to inform you that Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, Annual General Meeting of the Company is scheduled to be held on Friday, the 27th September, 2019 and the Register of Members and Share Transfer Books of the Company will remain closed from Saturday, 21st day of September, 2019 to Friday, 27th day of September, 2019 (both days inclusive) for the purpose of Annual General Meeting. Kindly take the same on your record and display the same on the website of your Stock Exchange.
27-08-2019
Bigul

Parmax Pharma Ltd - 540359 - Unaudited Financial Results For Quarter Ended On 30Th June, 2019

 This is to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. 9th August, 2019, inter-alia, considered and approved the Unaudited Financial Results for quarter ended 30th June, 2019. The same has also been reviewed by the Audit Committee in its meeting held today. A copy of the Statement of Unaudited Financial Results for the quarter ended 30th June, 2019, approved by the Board pursuant to Regulation 33 of the Securities And Exchange Board of India (LODR Regulations, 2015, is enclosed for your reference and record. A copy thereof has also been sent for publication as per the requirements. The meeting commenced at 11:00 am and concluded 4:30 pm. We would like to submit that M/ s. B A Shah S R Mehta & Co., Statutory Auditors of Company have carried out limited review of Unaudited Financial Results for quarter ended 30th June, 2019 and Board has also taken on record their Limited Review Report on said Results. Kindly take this on your records.
09-08-2019
Bigul

Parmax Pharma Ltd - 540359 - Outcome of Board Meeting

 This is to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. 9th August, 2019, inter-alia, considered and approved the Unaudited Financial Results for quarter ended 30th June, 2019. The same has also been reviewed by the Audit Committee in its meeting held today. A copy of the Statement of Unaudited Financial Results for the quarter ended 30th June, 2019, approved by the Board pursuant to Regulation 33 of the Securities And Exchange Board of India (LODR Regulations, 2015, is enclosed for your reference and record. A copy thereof has also been sent for publication as per the requirements. The meeting commenced at 11:00 am and concluded 4:30 pm. We would like to submit that M/ s. B A Shah S R Mehta & Co., Statutory Auditors of Company have carried out limited review of Unaudited Financial Results for quarter ended 30th June, 2019 and Board has also taken on record their Limited Review Report on said Results. Kindly take this on your records.
09-08-2019
Bigul

Parmax Pharma Ltd - 540359 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 In terms of Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached a copy of the advertisement published in Financial Express dated 3rd August, 2019 intimating that a Board Meeting of the Company is scheduled to be convened on Friday, the 9th August, 2019 to inter-alia, consider, approve and take on record the Unaudited Financial results of the Company for the quarter ended on 30th June, 2019.
06-08-2019
Bigul

Parmax Pharma Ltd - 540359 - Board Meeting Intimation for Intimation Of Board Meeting In Compliance With Reg. 29 Read With Reg. 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2019 ,inter alia, to consider and approve Dear Sir/Madam, With reference to the captioned subject, we would like to inform you that the Meeting of the Board of Directors of Parmax Pharma Limited will be held on Friday, 9th August, 2019 at 11.00 AM at the registered office of the company inter alia to consider, approve the Unaudited Financial Results for the quarter ended 30th June, 2019 and to discuss any other matter with the permission of Board.
02-08-2019
Bigul

Parmax Pharma Ltd - 540359 - Shareholding for the Period Ended June 30, 2019

 Parmax Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here
22-07-2019
Bigul

Parmax Pharma Ltd - 540359 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We submit herewith the confirmation certificate received from M/s. Purva Shregistey India Private Limited,Registrar and Share Transfer Agent (RTA) as per regulation 74(5) of the SEBl (Depositories and Participants) Regulations, 2018 for the quarter ended June 30,2019 Thanking you,
12-07-2019
Bigul

Parmax Pharma Ltd - 540359 - Statement Of Investor Complaints For The Quarter Ended June 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- YASH J. VORADesignation :- Company Secretary and Compliance Officer
09-07-2019
Bigul

Parmax Pharma Ltd - 540359 - Closure of Trading Window

 Closure of trading window
01-07-2019
Bigul

Parmax Pharma Ltd - 540359 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In compliance of SEBI Circular No. SEBI/HO/MIRSD/DOS3/CIR/P/2018/139 dated 6th November, 2018. The Company have published the general notice seeking objection if any, from concerned person(s) having any claim in respect of proposed transfer as lodged to the our RTA by the transferee for transfer of shares in their favor. The Newspaper advertisement is published in the Financial Express (English and Gujarati Edition) dated 8th June, 2019. The mandated information of proposed transfer is mentioned in the advertisement. Copy of Newspaper advertisement is enclosed herewith and it is also available on Company's Website i.e. www.parmaxpharma.com . Kindly take the same on records.
08-06-2019
Next Page
Close

Let's Open Free Demat Account